IDEAS home Printed from https://ideas.repec.org/p/osf/socarx/z5mf6.html
   My bibliography  Save this paper

Power, Disputes, and Geopolitics in the Pharmaceutical Sector

Author

Listed:
  • Stacciarini, João Henrique Santana

    (Federal University of Goiás)

Abstract

The pharmaceutical sector achieved global revenues of USD 1.6 trillion in 2023, underscoring its immense economic power and strategic influence on the modern economy and global politics. This article, grounded in extensive data collection, systematization, and analysis, explores the dynamics of this power and influence. It examines the economic and political value of companies in the sector, the conflicts between corporations and nations, the geopolitical role of the sector during the COVID-19 pandemic, and its capacity to shape domestic policies through intensive lobbying, financial contributions to lawmakers, and interactions with regulatory and oversight bodies.

Suggested Citation

  • Stacciarini, João Henrique Santana, 2024. "Power, Disputes, and Geopolitics in the Pharmaceutical Sector," SocArXiv z5mf6, Center for Open Science.
    • Handle: RePEc:osf:socarx:z5mf6
    DOI: 10.31219/osf.io/z5mf6
    as

    Download full text from publisher

    File URL: https://osf.io/download/67785b2fbcf73b5107828fc7/
    Download Restriction: no
    File URL: https://libkey.io/10.31219/osf.io/z5mf6?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Darius N. Lakdawalla, 2018. "Economics of the Pharmaceutical Industry," Journal of Economic Literature, American Economic Association, vol. 56(2), pages 397-449, June.
    2. Salamon, Lester M. & Siegfried, John J., 1977. "Economic Power and Political Influence: The Impact of Industry Structure on Public Policy," American Political Science Review, Cambridge University Press, vol. 71(3), pages 1026-1043, September.
    3. Priya Gauttam & Bawa Singh & Jaspal Kaur, 2020. "COVID-19 and Chinese Global Health Diplomacy: Geopolitical Opportunity for China’s Hegemony?," Millennial Asia, , vol. 11(3), pages 318-340, December.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Francis,David C. & Kubinec ,Robert, 2022. "Beyond Political Connections : A Measurement Model Approach to Estimating Firm-levelPolitical Influence in 41 Economies," Policy Research Working Paper Series 10119, The World Bank.
    2. Behnam Karamshahi & Zeinab Azami & Tabandeh Salehi, 2018. "The association between competition power in markets and tax avoidance: evidence from Tehran stock exchange," Eurasian Business Review, Springer;Eurasia Business and Economics Society, vol. 8(3), pages 323-339, September.
    3. Mauro Caselli & Arpita Chatterjee & Shengyu Li, 2023. "Productivity and Quality of Multi-product Firms," Discussion Papers 2023-10, School of Economics, The University of New South Wales.
    4. Paul H. Rubin & Mark A. Cohen, 1992. "Politically Imposed Entry Barriers," Eastern Economic Journal, Eastern Economic Association, vol. 18(3), pages 333-344, Summer.
    5. Brian Kelleher Richter & Krislert Samphantharak & Jeffrey F. Timmons, 2009. "Lobbying and Taxes," American Journal of Political Science, John Wiley & Sons, vol. 53(4), pages 893-909, October.
    6. Ted Hayduk, 2022. "Association membership, election cycles, and political donation patterns," Economics of Governance, Springer, vol. 23(3), pages 359-384, December.
    7. Sverker Sikström & Laura Mai Stoinski & Kristina Karlsson & Lotta Stille & Johan Willander, 2020. "Weighting power by preference eliminates gender differences," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-19, November.
    8. Richard Damania & Per G. Fredriksson & Thomas Osang, 2005. "Polluters and Collective Action: Theory and Evidence," Southern Economic Journal, John Wiley & Sons, vol. 72(1), pages 167-185, July.
    9. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
    10. repec:zbw:bofitp:2013_006 is not listed on IDEAS
    11. Tomaso Duso & Astrid Jung, 2003. "Market Conduct and Endogenous Lobbying: Evidence from the U.S. Mobile Telecommunications Industry," Vienna Economics Papers vie0315, University of Vienna, Department of Economics.
    12. Gianfranco Marotta & Phillipe Krahnhof & Cam-Duc Au, 2022. "A Critical Analysis of Budgeting Processes from the Pharmaceutical Industry and Beyond," Journal of Applied Finance & Banking, SCIENPRESS Ltd, vol. 12(3), pages 1-3.
    13. Suppliet, Moritz, 2020. "Umbrella branding in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 73(C).
    14. Paupini, Cristina & van der Zeeuw, Alex & Fiane Teigen, Helene, 2022. "Trust in the institution and privacy management of Internet of Things devices. A comparative case study of Dutch and Norwegian households," Technology in Society, Elsevier, vol. 70(C).
    15. Atal, Juan Pablo & Cuesta, José Ignacio & Sæthre, Morten, 2018. "Quality Regulation and Competition: Evidence from Pharmaceutical Markets," Discussion Paper Series in Economics 20/2018, Norwegian School of Economics, Department of Economics.
    16. Georges Siotis & Carmine Ornaghi & Micael Castanheira, 2023. "Evolving market boundaries and competition policy enforcement in the pharmaceutical industry," European Journal of Law and Economics, Springer, vol. 55(2), pages 313-348, April.
    17. Nakamura, Hiroshi & Wakutsu, Naohiko, 2020. "Reducing Reimbursement Drug Price Risk to Enhance R&D Incentives without Raising Drug Prices/Expenditures: Implications of Simulations Based on Questionnaire Survey of Pharmaceutical Companies in Japa," Health Policy, Elsevier, vol. 124(7), pages 714-720.
    18. Arnold, Denis G. & Amato, Louis H. & Troyer, Jennifer L. & Stewart, Oscar Jerome, 2022. "Innovation and misconduct in the pharmaceutical industry," Journal of Business Research, Elsevier, vol. 144(C), pages 1052-1063.
    19. Gianluca Antonecchia & Ajay Bhaskarabhatla & Enrico Pennings, 2024. "Bargaining Power and Quantity Discounts to Retailers: Evidence from India’s Pharmaceutical Industry," Tinbergen Institute Discussion Papers 24-048/VII, Tinbergen Institute.
    20. Ryan M. Weldzius, 2021. "The end of currency manipulation? Global production networks and exchange rate outcomes," Economics and Politics, Wiley Blackwell, vol. 33(3), pages 514-532, November.
    21. Jiemiao Dong & Zhuangxiong Yu & Xunpeng Shi & Yang Yang, 2024. "Industrial Policy, Product Switching, and Export Performance," China & World Economy, Institute of World Economics and Politics, Chinese Academy of Social Sciences, vol. 32(1), pages 167-196, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:osf:socarx:z5mf6. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: OSF (email available below). General contact details of provider: https://arabixiv.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.